20 – MONITORING PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS

[1]  A. Voss,et al.  A multicentre study of 513 Danish patients with systemic lupus erythematosus. II. Disease mortality and clinical factors of prognostic value , 2005, Clinical Rheumatology.

[2]  B. Diamond,et al.  A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus , 2001, Nature Medicine.

[3]  L. Magder,et al.  A decrease in complement is associated with increased renal and hematologic activity in patients with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[4]  L. Magder,et al.  Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. , 2001, Arthritis and rheumatism.

[5]  M. van Buchem,et al.  Imaging modalities in central nervous system systemic lupus erythematosus , 2001, Current opinion in rheumatology.

[6]  L. Liou.  Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. , 2001, Clinical and experimental rheumatology.

[7]  J. Peltola,et al.  The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus , 2001, Neurology.

[8]  S. Wani,et al.  Systemic lupus erythematosus presenting with acute fatal pancreatitis as an initial manifestation. , 2001 .

[9]  D. Gladman,et al.  Significance of isolated hematuria and isolated pyuria in systemic lupus erythematosus , 2001, Lupus.

[10]  S. Misbah,et al.  Is it useful to test for antibodies to extractable nuclear antigens in the presence of a negative antinuclear antibody on Hep-2 cells? , 2001, Journal of clinical pathology.

[11]  M. Pavlović,et al.  Skin lesions - an indicator of disease activity in systemic lupus erythematosus? , 2001, Lupus.

[12]  F. Howe,et al.  Sensitivity of quantitative 1H magnetic resonance spectroscopy of the brain in detecting early neuronal damage in systemic lupus erythematosus , 2001 .

[13]  D. Gladman,et al.  Early damage as measured by the SLICC/ACR damage index is a predictor of mortality in systemic lupus erythematosus , 2001, Lupus.

[14]  J. Naschitz.  Rheumatic syndromes: clues to occult neoplasia , 1999, Current opinion in rheumatology.

[15]  T. Witte,et al.  Prognostic parameters for flare in systemic lupus erythematosus. , 2000, Rheumatology.

[16]  T. Matsuo,et al.  Cytomegalovirus associated pancreatitis in a patient with systemic lupus erythematosus. , 2000, The Journal of rheumatology.

[17]  M. Piga,et al.  Central nervous system involvement in systemic lupus erythematosus: cerebral imaging and serological profile in patients with and without overt neuropsychiatric manifestations , 2000, Lupus.

[18]  S. Chow,et al.  The spectrum of ocular involvement in patients with systemic lupus erythematosus without ocular symptoms , 2000, Lupus.

[19]  G. Cheema,et al.  Interstitial lung disease in systemic lupus erythematosus. , 2000, Current opinion in pulmonary medicine.

[20]  D. Power,et al.  Chronic intestinal pseudo-obstruction in systemic lupus erythematosus due to intestinal smooth muscle myopathy , 2000, Lupus.

[21]  M. Abrahamowicz,et al.  Do lupus disease activity measures detect clinically important change? , 2000, The Journal of rheumatology.

[22]  A. Teppo,et al.  Decreased urinary excretion of vascular endothelial growth factor in idiopathic membranous glomerulonephritis. , 2000, Kidney international.

[23]  W. Egner.  The use of laboratory tests in the diagnosis of SLE , 2000, Journal of clinical pathology.

[24]  W M Brutinel,et al.  The shrinking lungs syndrome in systemic lupus erythematosus. , 2000, Mayo Clinic proceedings.

[25]  R. Nezlin.  A quantitative approach to the determination of antigen in immune complexes. , 2000, Journal of immunological methods.

[26]  M. Ward,et al.  Comparison of the validity and sensitivity to change of 5 activity indices in systemic lupus erythematosus. , 2000, The Journal of rheumatology.

[27]  A. Drosos,et al.  Extensive lymphadenopathy as the first clinical manifestation in systemic lupus erythematosus , 2000, Lupus.

[28]  D. Gladman,et al.  The Systemic Lupus International Collaborating Clinics/American College of Rheumatology (SLICC/ACR) Damage Index for Systemic Lupus Erythematosus International Comparison. , 2000, The Journal of rheumatology.

[29]  Mimi Y. Kim,et al.  Classification and definition of major flares in SLE clinical trials , 1999, Lupus.

[30]  D. Gladman,et al.  Guidelines for referral and management of systemic lupus erythematosus in adults. American College of Rheumatology Ad Hoc Committee on Systemic Lupus Erythematosus Guidelines. , 1999, Arthritis and rheumatism.

[31]  L. Bonomo,et al.  Retinopathy in systemic lupus erythematosus: pathogenesis and approach to therapy. , 1999, Human immunology.

[32]  D. Wallace,et al.  Pierre Cazenave and the first detailed modern description of lupus erythematosus. , 1999, Seminars in arthritis and rheumatism.

[33]  Caroline Gordon,et al.  The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. , 1999, Arthritis and rheumatism.

[34]  T. Miller,et al.  Cardiac involvement in systemic lupus erythematosus. , 1999, Mayo Clinic proceedings.

[35]  Y. Shoenfeld,et al.  β2 glycoprotein I containing immune-complexes in lupus patients: association with thrombocytopenia and lipoprotein (a) levels , 1999, Lupus.

[36]  P. Tugwell,et al.  Outcome measures to be used in clinical trials in systemic lupus erythematosus. , 1999, The Journal of rheumatology.

[37]  D. Boumpas,et al.  Outcome criteria for lupus nephritis trials: A critical overview , 1998, Lupus.

[38]  L. Moist,et al.  Management of chronic renal insufficiency in lupus nephritis: Role of proteinuria, hypertension and dyslipidemia in the progression of renal disease , 1998, Lupus.

[39]  Y. Shoenfeld,et al.  Immunochemical determination of DNA in immune complexes present in the circulation of patients with systemic lupus erythematosus. , 1998, Journal of autoimmunity.

[40]  D. Gladman,et al.  Fatigue in lupus is not correlated with disease activity. , 1998, The Journal of rheumatology.

[41]  A. Teppo,et al.  Adhesion molecules and urinary tumor necrosis factor-alpha in idiopathic membranous glomerulonephritis. , 1998, Kidney international.

[42]  M. Weisman,et al.  Corticosteroids and systemic lupus erythematosus pancreatitis: a case series. , 1998, The Journal of rheumatology.

[43]  L. Jara,et al.  Pulmonary hemorrhage in systemic lupus erythematosus , 1997, Lupus.

[44]  E. Tan,et al.  Standards of care: the value and importance of standardization. , 1997, Arthritis and rheumatism.

[45]  C. Gordon,et al.  A Damage Index for Lupus Patients — Where are we now? , 1997, Lupus.

[46]  Y. Takasaki,et al.  Reference sera for antinuclear antibodies. II. Further definition of antibody specificities in international antinuclear antibody reference sera by immunofluorescence and western blotting. , 1997, Arthritis and rheumatism.

[47]  S. Quaglini,et al.  "Nephritic flares" are predictors of bad long-term renal outcome in lupus nephritis. , 1996, Kidney international.

[48]  A. Piccoli,et al.  Review : Photosensitivity in systemic lupus erythematosus: laboratory testing of ARA/ACR definition , 1996, Lupus.

[49]  M. Abrahamowicz,et al.  Laboratory tests as predictors of disease exacerbations in systemic lupus erythematosus. Why some tests fail. , 1996, Arthritis and rheumatism.

[50]  G. Hughes,et al.  Association of antiphospholipid antibodies with central nervous system disease in systemic lupus erythematosus. , 1995, The American journal of medicine.

[51]  E. Lewis,et al.  Relationship between appearance of urinary red blood cell/white blood cell casts and the onset of renal relapse in systemic lupus erythematosus. , 1995, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[52]  V. Rodríguez-Valverde,et al.  Acute reversible hypoxemia in systemic lupus erythematosus: a new syndrome or an index of disease activity? , 1995, Lupus.

[53]  P. Limburg,et al.  Prevention of relapses in systemic lupus erythematosus , 1995, The Lancet.

[54]  B. Fessler,et al.  Systemic Lupus Erythematosus: Emerging Concepts: Part 1: Renal, Neuropsychiatric, Cardiovascular, Pulmonary, and Hematologic Disease , 1995, Annals of Internal Medicine.

[55]  C. Kallenberg,et al.  Review : Serological markers of disease activity in systemic lupus erythematosus , 1995, Lupus.

[56]  D. Gladman,et al.  Serologically active clinically quiescent systemic lupus erythematosus--predictors of clinical flares. , 1994, The Journal of rheumatology.

[57]  S. Levine,et al.  Large cerebral vessel occlusive disease in systemic lupus erythematosus , 1994, Neurology.

[58]  M. Lockshin,et al.  Neurologic complications of antiphospholipid antibodies. , 1993, Rheumatic diseases clinics of North America.

[59]  J. Buyon.  Review: Congenital Complete Heart Block , 1993 .

[60]  D A Isenberg,et al.  The BILAG index: a reliable and valid instrument for measuring clinical disease activity in systemic lupus erythematosus. , 1993, The Quarterly journal of medicine.

[61]  A. Silman,et al.  VALIDITY AND RELIABILITY OF THREE METHODS USED IN THE DIAGNOSIS OF RAYNAUD'S PHENOMENON , 1993 .

[62]  J. Buyon,et al.  Congenital complete heart block , 1990 .

[63]  S. Gabriel,et al.  A reliability study of SLEDAI: a disease activity index for systemic lupus erythematosus. , 1993, The Journal of rheumatology.

[64]  D. Isenberg,et al.  Disease activity in systemic lupus erythematosus: report of the Consensus Study Group of the European Workshop for Rheumatology Research. I. A descriptive analysis of 704 European lupus patients. European Consensus Study Group for Disease Activity in SLE. , 1992, Clinical and experimental rheumatology.

[65]  D. Kiprov,et al.  Thrombotic thrombocytopenic purpura complicating systemic lupus erythematosus. Case report and literature review from the plasmapheresis era. , 1992, The Journal of rheumatology.

[66]  R. Derksen,et al.  Anti-Ro/SS-A and anti-La/SS-B autoantibody levels in relation to systemic lupus erythematosus disease activity and congenital heart block. A longitudinal study comprising two consecutive pregnancies in a patient with systemic lupus erythematosus. , 1992, Arthritis and rheumatism.

[67]  P. Spronk,et al.  Patients with systemic lupus erythematosus and Jaccoud's arthropathy: a clinical subset with an increased C reactive protein response? , 1992, Annals of the rheumatic diseases.

[68]  Marja,et al.  Prospective study of fluctuations of lupus anticoagulant activity and anticardiolipin antibody titre in patients with systemic lupus erythematosus. , 1992, Annals of the rheumatic diseases.

[69]  M. Petri,et al.  Validity and reliability of lupus activity measures in the routine clinic setting. , 1992, The Journal of rheumatology.

[70]  L. Leibovici,et al.  Alopecia in systemic lupus erythematosus. Relation to disease manifestations. , 1991, The Journal of rheumatology.

[71]  D. Rapoport,et al.  Acute reversible hypoxemia in systemic lupus erythematosus. , 1991, Annals of internal medicine.

[72]  P. Limburg,et al.  C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. , 1990, The Journal of rheumatology.

[73]  N. Larocca,et al.  A study of fatigue in systemic lupus erythematosus. , 1990, The Journal of rheumatology.

[74]  D. Isenberg,et al.  Correlation between clinical features of systemic lupus erythematosus and levels of antihistone antibodies of the IgG, IgA, and IgM isotypes. , 1990, Annals of the rheumatic diseases.

[75]  M. Liang,et al.  Effects of aerobic conditioning in lupus fatigue: a pilot study. , 1989, British journal of rheumatology.

[76]  M. Liang,et al.  Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. , 1989, Arthritis and rheumatism.

[77]  J. Fries,et al.  Prevalence and expression of photosensitivity in systemic lupus erythematosus. , 1989, Annals of the rheumatic diseases.

[78]  D. Symmons,et al.  Development and Assessment of a Computerized Index of Clinical Disease Activity in Systemic Lupus Erythematosus , 1988 .

[79]  M. Liang,et al.  Measurement of systemic lupus erythematosus activity in clinical research. , 1988, Arthritis and rheumatism.

[80]  J. Kelton,et al.  Hypergammaglobulinemia can be associated with a positive direct antiglobulin test, a nonreactive eluate, and no evidence of hemolysis , 1988, Transfusion.

[81]  C. Beattie,et al.  Retinopathy in systemic lupus erythematosus: relationship to disease activity. , 1986 .

[82]  A. Swaak,et al.  Predictive value of complement profiles and anti-dsDNA in systemic lupus erythematosus. , 1986, Annals of the rheumatic diseases.

[83]  S. Fine,et al.  Severe retinal vaso-occlusive disease in systemic lupus erythematous. , 1986, Archives of ophthalmology.

[84]  M. Pepys,et al.  Serum C-reactive protein measurement in the detection of intercurrent infection in Oriental patients with systemic lupus erythematosus. , 1985, Annals of the rheumatic diseases.

[85]  Urowitz Mb,et al.  Shrinking lung syndrome in SLE--a clinical pathologic study. , 1983 .

[86]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[87]  T. Zizic,et al.  Acute abdominal complications of systemic lupus erythematosus and polyarteritis nodosa. , 1982, The American journal of medicine.

[88]  M. Pepys,et al.  C-reactive protein in SLE. , 1982, Clinics in rheumatic diseases.

[89]  P. Schur,et al.  Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus (SLE). , 1981, Medicine.

[90]  G. Hughes,et al.  Value of serum C-reactive protein measurement in the investigation of fever in systemic lupus erythematosus. , 1980, Annals of the rheumatic diseases.

[91]  L. Espinoza,et al.  The relationship between C-reactive protein and systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[92]  A. Claudy,et al.  Disease activity in systemic lupus erythematosus , 1979, Clinical and experimental dermatology.

[93]  J. Klippel,et al.  Fever in systemic lupus erythematosus. , 1979, The American journal of medicine.

[94]  M. Miniter,et al.  Reassessment of the clinical significance of native DNA antibodies in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[95]  L. Aarden,et al.  Anti-dsDNA and complement profiles as prognostic guides in systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[96]  I. Kushner,et al.  Significance of serum C-reactive protein elevation in patients with systemic lupus erythematosus. , 1979, Arthritis and rheumatism.

[97]  F. Arnett,et al.  NEUROPSYCHIATRIC MANIFESTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS: DIAGNOSIS, CLINICAL SPECTRUM, AND RELATIONSHIP TO OTHER FEATURES OF THE DISEASE , 1976, Medicine.

[98]  J. Andreasen.  ORAL MANIFESTATIONS IN DISCOID AND SYSTEMIC LUPUS ERYTHEMATOSUS. I. CLINICAL INVESTIGATION. , 1964, Acta odontologica Scandinavica.

[99]  L. Shulman,et al.  SYSTEMIC LUPUS ERYTHEMATOSUS: REVIEW OF THE LITERATURE AND CLINICAL ANALYSIS OF 138 CASES , 1954, Medicine.